Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Deferred Revenue (2019 - 2025)

Cellebrite DI (CLBT) has 6 years of Current Deferred Revenue data on record, last reported at $277.6 million in Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 27.94% year-over-year to $277.6 million; the TTM value through Dec 2025 reached $277.6 million, up 27.94%, while the annual FY2025 figure was $277.6 million, 27.94% up from the prior year.
  • Current Deferred Revenue reached $277.6 million in Q4 2025 per CLBT's latest filing, up from $217.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $277.6 million in Q4 2025 and bottomed at $159.4 million in Q4 2021.
  • Average Current Deferred Revenue over 5 years is $218.3 million, with a median of $217.0 million recorded in 2024.
  • Peak YoY movement for Current Deferred Revenue: decreased 10.65% in 2024, then increased 27.94% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $159.4 million in 2021, then grew by 22.25% to $194.9 million in 2022, then increased by 24.6% to $242.8 million in 2023, then fell by 10.65% to $217.0 million in 2024, then rose by 27.94% to $277.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $277.6 million in Q4 2025, $217.0 million in Q4 2024, and $242.8 million in Q4 2023.